PatentsGlobal
AimwellBio Enhances Behavioral Engagement Platform with Trustr IP Acquisition and Dr. Chris A. Jones Joining Advisory Board
AimwellBio has released a detailed investor briefing on its newly acquired Trustr intellectual property portfolio, valued at $10 million. The portfolio centers on patented systems designed to influence real-world patient behavior through personalized performance metrics and timed behavioral messaging. The company also…
Thursday, August 13, 2026